Claritev Corporation (CTEV) is a publicly traded Healthcare sector company. As of August 26, 2026, CTEV trades at $37.05 with a market cap of $619.94M and a P/E ratio of -2.21. CTEV moved -1.39% today. Year to date, CTEV is +11.07%; over the trailing twelve months it is -47.44%. Its 52-week range spans $11.50 to $74.07. Analyst consensus is strong buy with an average price target of $45.83. Rallies surfaces CTEV's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Claritev Corporation (CTEV) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. CTEV moved -1.39% today. Analyst consensus is strong buy.
| Metric | Value |
|---|---|
| Price | $37.05 |
| Market Cap | $619.94M |
| P/E Ratio | -2.21 |
| EPS | $-17.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $74.07 |
| 52-Week Low | $11.50 |
| Volume | 28.86K |
| Avg Volume | 0 |
| Revenue (TTM) | $994.67M |
| Net Income | $-283.11M |
| Gross Margin | 0.00% |
6 analysts cover CTEV: 0 strong buy, 5 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $45.83.